Anti-alpha Gal Polyclonal Antibody R-PE Conjugate1vial

4-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile, 98.0%, 250mg

Tartrazina (CI 19140), 25 g, envase de vidrio

N-[5-(Benzylsulfanyl)-1,3,4-thiadiazol-2-yl]propanamide, 98.0%, 50mg

(4-(Difluoromethoxy)-2-fluorophenyl)boronic acid, 95+%, 100mg

Ethyl 2-(tert-butyl)thiazole-5-carboxylate, 97%, 100mg

(4-Butoxy-3-fluorophenyl)boronic acid, 95.0%, 5g

2,5-Dibromo-3-nitropyridine>98.0%(GC)1g

Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate, 95.0%, 250mg

n',n'-Diphenyl-1h-pyrrole-2-carbohydrazide, 98%, 5g

2,3,4,5,6-Pentafluorostyrene, 99.0%, 10g

4-Aminoindoline-2,3-dione, 97%, 1g

3-Phenyl-1-propanol>98.0%(GC)500mL